Gene delivery by functional inorganic nanocarriers

Recent Patents on DNA and Gene Sequences

Volumn 6, Issue 2, 2012, Pages 108-114

  Loh, Xian Jun ^a   Lee, Tung Chun ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MAX PLANCK INSTITUTE FOR INTELLIGENT SYSTEMS   (Germany)

Author keywords

Carbon nanotubes; Cationic polymers; Gene delivery; Gold; Inorganic nanoparticles; Iron oxide; Lipids; Peptides; Silica; Viruses

Indexed keywords

CARBON NANOTUBE; DOUBLE STRANDED DNA; GLUTATHIONE; GOLD NANOPARTICLE; INORGANIC NANOPARTICLE; IRON OXIDE NANOPARTICLE; MAGNETIC NANOPARTICLE; MOLECULAR SCAFFOLD; MULTI WALLED NANOTUBE; NANOCARRIER; NANOPARTICLE; PLASMID DNA; POLYETHYLENEIMINE; QUANTUM DOT; SILICON DIOXIDE; SINGLE STRANDED DNA; SINGLE WALLED NANOTUBE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ENZYME DEGRADATION; GENE DELIVERY SYSTEM; GENE MUTATION; GENE TARGETING; GENE THERAPY; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; LIPOSOMAL GENE DELIVERY SYSTEM; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OSTEOSARCOMA; PARTICLE SIZE; PATENT; PRIORITY JOURNAL; REVIEW; SUICIDE GENE; VIRAL GENE DELIVERY SYSTEM;

EID: 84863916364     PISSN: 18722156     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221512801327361     Document Type: Review

References (74)

1. Drumm ML, Pope HA, Cliff WH, et al. Correction of the cysticfibrosis defect in vitro by retrovirus-mediated gene-transfer. Cell 1990; 62(6): 1227-33.
2. Kaplitt MG, Feigin A, Tang C, et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 2007; 369(9579): 2097-105.
3. McFarland TJ, Zhang Y, Appukuttan B, Stout JT. Gene therapy for proliferative ocular diseases. Expert Opin Biol Th 2004; 4(7): 1053-8.
4. Pai SI, Lin YY, Macaes B, Meneshian A, Hung CF, Wu TC. Prospects of RNA interference therapy for cancer. Gene Therapy 2006; 13(6): 464-77.
5. Dobson J. Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Ther 2006; 13(4): 283-7.
6. Ghosh P, Han G, De M, Kim CK, Rotello VM. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 2008; 60(11): 1307-15.
7. Li J, Loh XJ. Cyclodextrin-based supramolecular architectures: Syntheses, structures, and applications for drug and gene delivery. Adv Drug Deliv Rev 2008; 60(9): 1000-17.
8. Liu G, Swierczewska M, Lee S, Chen X. Functional nanoparticles for molecular imaging guided gene delivery. Nano Today 2010; 5(6): 524-39.
9. Thomas M, Klibanov AM. Non-viral gene therapy: polycationmediated DNA delivery. Appl Microbiol Biotechnol 2003; 62(1): 27-34.
10. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 2004; 56(11): 1649-59.
11. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 2002; 54(5): 631-51.
12. Baban DF, Seymour LW. Control of tumour vascular permeability. Adv Drug Deliv Rev 1998; 34(1): 109-19.
13. Bergen JM, Von Recum HA, Goodman TT, Massey AP, Pun SH. Gold nanoparticles as a versatile platform for optimizing physicochemical parameters for targeted drug delivery. Macromol Biosci 2006; 6(7): 506-16.
14. Han G, You CC, Kim BJ, et al. Light-regulated release of DNA and its delivery to nuclei by means of photolabile gold nanoparticles. Angew Chem Int Ed 2006; 45(19): 3165-69.
15. Hong R, Han G, Fernandez JM, Kim BJ, Forbes NS, Rotello VM. Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. J Am Chem Soc 2006; 128(4): 1078-9.
16. Polizzi MA, Stasko NA, Schoenfisch MH. Water-soluble nitric oxide-releasing gold nanoparticles. Langmuir 2007; 23(9): 4938-43.
17. Lee Y, Lee SH, Kim JS, Maruyama A, Chen X, Park TG. Controlled synthesis of PEI-coated gold nanoparticles using reductive catechol chemistry for siRNA delivery. J Control Release 2011; 155(1): 3-10.
18. Cebrian V, Martin-Saavedra F, Yaguee C, Arruebo M, Santamaria J, Vilaboa N. Size-dependent transfection efficiency of PEI-coated gold nanoparticles. Acta Biomater 2011; 7(10): 3645-55.
19. Agbasi-Porter C, Ryman-Rasmussen J, Franzen S, Feldheim D. Transcription inhibition using oligonucleotide-modified gold nanoparticles. Bioconjug Chem 2006; 17(5): 1178-83.
20. Rosi NL, Giljohann DA, Thaxton CS, Lytton-Jean AKR, Han MS, Mirkin CA. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 2006; 312(5776): 1027-30.
21. Sandhu KK, McIntosh CM, Simard JM, Smith SW, Rotello VM. Gold nanoparticle-mediated Transfection of mammalian cells. Bioconjug Chem 2002; 13(1): 3-6.
22. Thomas M, Klibanov AM. Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells. Proc Natl Acad Sci USA 2003; 100(16): 9138-43.
23. Tsai CY, Shiau AL, Cheng PC, et al. A biological strategy for fabrication of Au/EGFP nanoparticle conjugates retaining bioactivity. Nano Letters 2004; 4(7): 1209-12.
24. Han MS, Lee K, Kim DE, inventors. Nanoparticle-Based Gene Delivery Systems. US20110229966, 2011.
25. Niitome T, Niitome Y, Nakajima K, et al, inventors. Cationic gold nanoparticle, polyethylene glycol-modified cationic gold nanoparticle and complex thereof with nucleic acid. JP 2005287507, 2005.
26. Prasad LVB, Periyasamy SV, Othalathara UA, Bashir MK. DNA loaded supported gold nanoparticles, process for the preparation and use thereof. WO/2011/016053, 2011.
27. Bao G, Nie S, Nitin N, LaConte L. Multifunctional magnetic nanoparticle probes for intracellular molecular imaging and monitoring. US 2005/0130167, 2005.
28. Josephson L, Weissleder R, Perez JM. Magneitc-nanoparticle conjugates and methods of use. US 2003/0092029, 2003.
29. Cho H-J, Shih SM, Lin YJ, Lin HD, Lin KP. Magnetic nanoparticle. US 2005/0025971, 2005.
30. Carpenter EE, Carpenter V. Fluorescent-magnetic nanoparticles with core-shell structure. US 2004/0208825, 2004.
31. Hinds KA. Particles for imaging cells. US 2004/0109824, 2004.
32. Prasad PN, Bergey EJ, Liebow C, Levy L. Magnetic nanoparticles for selective therapy. US 6514481, 2003.
33. Bahr M, Berkov D, Buske N, Clement J, Grnert P, Hffken K, Kliche KO, Kober T, Schnabelrauch M, Vogt S, Wagner K, Gansau C. Magnetic nanoparticles having biochemical activity, method for the. US 6767635, 2004.
34. Liu C, Zou BS, Rondinone AJ, Zhang J. Chemical control of superparamagnetic properties of magnesium and cobalt spinel ferrite nanoparticles through atomic level magnetic couplings. J Am Chem Soc 2000; 122(26): 6263-67.
35. Zeng H, Li J, Liu JP, Wang ZL, Sun SH. Exchange-coupled nanocomposite magnets by nanoparticle self-assembly. Nature 2002; 420(6914): 395-8.
36. Babes L, Denizot B, Tanguy G, Le Jeune JJ, Jallet P. Synthesis of iron oxide nanoparticles used as MRI contrast agents: A parametric study. J Colloid Interface Sci 1999; 212(2): 474-82.
37. Perez JM, Josephson L, O'Loughlin T, Hogemann D, Weissleder R. Magnetic relaxation switches capable of sensing molecular interactions. Nat Biotechnol 2002; 20(8): 816-820.
38. Perez JM, O'Loughin T, Simeone FJ, Weissleder R, Josephson L. DNA-based magnetic nanoparticle assembly acts as a magnetic relaxation nanoswitch allowing screening of DNA-cleaving agents. J Am Chem Soc 2002; 124(12): 2856-7.
39. Yoon TJ, Lee W, Oh YS, Lee JK. Magnetic nanoparticles as a catalyst vehicle for simple and easy recycling. New J Chem 2003; 27(2): 227-9.
40. Doyle PS, Bibette J, Bancaud A, Viovy JL. Self-assembled magnetic matrices for DNA separation chips. Science 2002; 295(5563): 2237-7.
41. Gu HW, Ho PL, Tsang KWT, Wang L, Xu B. Using biofunctional magnetic nanoparticles to capture vancomycin-resistant enterococci and other gram-positive bacteria at ultralow concentration. J Am Chem Soc 2003; 125(51): 15702-3.
42. Cao DF, He PL, Hu NF. Electrochemical biosensors utilising electron transfer in heme proteins immobilised on Fe3O4 nanoparticles. Analyst 2003; 128(10): 1268-74.
43. Wu EX, Tang HY, Wong KK, Wang J. Mapping cyclic change of regional myocardial blood volume using steady-state susceptibility effect of iron oxide nanoparticles. J Magn Reson Imaging 2004; 19(1): 50-8.
44. Correa-Duarte MA, Giersig M, Kotov NA, Liz-Marzan LM. Control of packing order of self-assembled monolayers of magnetite nanoparticles with and without SiO(2) coating by microwave irradiation. Langmuir 1998; 14(22): 6430-5.
45. Lu Y, Yin YD, Mayers BT, Xia YN. Modifying the surface properties of superparamagnetic iron oxide nanoparticles through a sol-gel approach. Nano Letters 2002 Mar; 2(3): 183-6.
46. Lee J.-K, Cho, MH, Park SB, Yoon TJ. Multifunctional particles providing cellular uptake and magnetic motor effect. US 2010/0081130, 2010.
47. Bikram M. Ultrasmall superparamagnetic iron oxide nanoparticles and uses thereof. US 2010/0003197, 2010.
48. Mykhaylyk O, Sanchez-Antequera Y, Tresilwised N, et al. Engineering magnetic nanoparticles and formulations for gene delivery. J Control Release; 148(1): E63-E64.
49. Liu G, Xie J, Zhang F, et al. N-Alkyl-PEI-Functionalized Iron Oxide Nanoclusters for Efficient siRNA Delivery. Small 2011 4; 7(19): 2742-9.
50. Iijima S. Helical Microtubules of Graphitic Carbon. Nature 1991; 354(6348): 56-8.
51. Kam NWS, Liu Z, Dai HJ. Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. J Am Chem Soc 2005; 127(36): 12492-3.
52. Liu Z, Cai W, He L, et al. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotechnol 2007; 2(1): 47-52.
53. Liu Z, Robinson JT, Sun X, Dai H. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc 2008; 130(33): 10876-7.
54. Liu Z, Sun X, Nakayama-Ratchford N, Dai H. Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. Acs Nano 2007; 1(1): 50-6.
55. Pantarotto D, Singh R, McCarthy D, et al. Functionalized carbon nanotubes for plasmid DNA gene delivery. Angewandte Chemie-International Edition 2004; 43(39): 5242-6.
56. Liu Y, Wu DC, Zhang WD, et al. Polyethylenimine-grafted multiwalled carbon nanotubes for secure noncovalent immobilization and efficient delivery of DNA. Angewandte Chemie-International Edition 2005; 44(30): 4782-5.
57. Singh R, Pantarotto D, McCarthy D, et al. Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: Toward the construction of nanotube-based gene delivery vectors. J Am Chem Soc 2005; 127(12): 4388-96.
58. Prato M, Kostarelos K, Bianco A. Functionalized carbon nanotubes in drug design and discovery. Acc Chem Res 2008; 41(1): 60-8.
59. Gao XH, Cui YY, Levenson RM, Chung LWK, Nie SM. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotech 2004; 22(8): 969-76.
60. Gao XH, Yang LL, Petros JA, Marshal FF, Simons JW, Nie SM. In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol 2005; 16(1): 63-72.
61. Jamieson T, Bakhshi R, Petrova D, Pocock R, Imani M, Seifalian AM. Biological applications of quantum dots. Biomaterials 2007; 28(31): 4717-32.
62. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater 2005; 4(6):435-46.
63. Michalet X, Pinaud FF, Bentolila LA, et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005; 307(5709): 538-44.
64. Derfus AM, Chen AA, Min D-H, Ruoslahti E, Bhatia SN. Targeted quantum dot conjugates for siRNA delivery. Bioconjug Chem 2007; 18(5): 1391-6.
65. Li D, Li G, Guo W, Li P, Wang E, Wang J. Glutathione-mediated release of functional plasmid DNA from positively charged quantum dots. Biomaterials 2008 Jun; 29(18): 2776-82.
66. Li J-M, Zhao M-X, Su H, et al. Multifunctional quantum-dot-based siRNA delivery for HPV18 E6 gene silence and intracellular imaging. Biomaterials Nov; 32(31): 7978-87.
67. Zhao M-X, Li J-M, Du L, et al. Targeted Cellular Uptake and siRNA Silencing by Quantum-Dot Nanoparticles Coated with beta-Cyclodextrin Coupled to Amino Acids. Chemistry-a European J 2011 Apr; 17(18):5171-9.
68. Xia T, Kovochich M, Liong M, et al. Polyethyleneimine Coating Enhances the Cellular Uptake of Mesoporous Silica Nanoparticles and Allows Safe Delivery of siRNA and DNA Constructs. Acs Nano 2009 Oct; 3(10): 3273-86.
69. Radu DR, Lai CY, Jeftinija K, Rowe EW, Jeftinija S, Lin VSY. A polyamidoamine dendrimer-capped mesoporous silica nanospherebased gene transfection reagent. J Am Chem Soc 2004 Oct 20; 126(41): 13216-7.
70. Liu J, Stace-Naughton A, Brinker CJ. Silica nanoparticle supported lipid bilayers for gene delivery. Chem Commu 2009 2009(34): 5100-2.
71. Kienberger F, Costa LT, Zhu R, et al. Dynamic force microscopy imaging of plasmid DNA and viral RNA. Biomaterials 2007 May; 28(15): 2403-11.
72. Lewis RJ, Huang JH, Pecora R. Rotational and translational motion of supercoiled plasmids in solution. Macromolecules 1985; 18(5): 944-8.
73. Tam P, Monck M, Lee D, et al. Stabilized plasmid-lipid particles for systemic gene therapy. Gene Therapy 2000 Nov; 7(21): 1867-74.
74. Kim M-H, Na H-K, Kim Y-K, et al. Facile Synthesis of Monodispersed Mesoporous Silica Nanoparticles with Ultralarge Pores and Their Application in Gene Delivery. Acs Nano 2011 May; 5(5): 3568-76.